GW Pharma to market CBD child-epilepsy drug

With an FDA nod to GW Pharma, the CBD-based  anti-seizure medication Epilodex will be on the market before the end of 2018. First-of-its kind medical trial seizures in children with a rare, life-threatening type of epilepsy.
#cannabis